This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Toolgen Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Jeongjoon Lee: Innovator in CRISPR Technology
Introduction
Jeongjoon Lee is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of genetic engineering, particularly through his work with CRISPR technology. His innovative approach has led to advancements that enhance the specificity of genome editing.
Latest Patents
Jeongjoon Lee holds a patent for a "Target-specific CRISPR mutant." This invention relates to an artificially engineered CRISPR/Cas9 system. More specifically, it involves an artificially engineered CRISPR enzyme that possesses enhanced target specificity. The application of this invention includes genome and epigenome manipulation, genome targeting, genome editing, and in vitro diagnosis.
Career Highlights
Currently, Jeongjoon Lee is associated with Toolgen Inc., a company known for its focus on gene editing technologies. His work at Toolgen has positioned him as a key player in the development of advanced CRISPR systems. With a patent portfolio that includes 1 patent, he continues to push the boundaries of genetic research.
Collaborations
Jeongjoon Lee collaborates with notable colleagues such as Young-Hoon Kim and Min Hee Jung. Their combined expertise contributes to the innovative projects at Toolgen Inc.
Conclusion
Jeongjoon Lee's contributions to CRISPR technology exemplify the potential of genetic engineering in modern science. His work not only enhances the capabilities of genome editing but also paves the way for future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile